Literature DB >> 12454165

Antigenically diverse reference strains and autologous strains of Actinobacillus actinomycetemcomitans are equally efficient antigens in enzyme-linked immunosorbent assay analysis.

Tiina Vilkuna-Rautiainen1, Pirkko J Pussinen, Kimmo Mattila, Marja Vesanen, Heidi Ahman, Başak Doğan, Sirkka Asikainen.   

Abstract

Actinobacillus actinomycetemcomitans is a major pathogen in periodontitis. Data on the clinical relevance of serum immunoglobulin G (IgG) antibody levels against this species are controversial. The aim of the present study was to elucidate how different strains used as antigens in enzyme-linked immunosorbent assay (ELISA) influence the detection of individuals with elevated serum IgG levels against A. actinomycetemcomitans. We hypothesized that the highest antibody levels are targeted to the autologous strains. A total of 19 strains-six antigenically diverse reference strains (serotypes a through e and a nonserotypeable strain) and 13 serotyped autologous strains-were used as whole-cell antigens in ELISA. Serum samples were from 26 untreated adult patients with periodontitis, whose subgingival bacterial samples were either culture positive (n = 13) or culture negative (n = 13) for A. actinomycetemcomitans, and from 10 culture-negative nonperiodontitis subjects. The highest individual (P < 0.05) IgG levels against the reference strains were most commonly against serotypes a and b in patients and against serotype c in nonperiodontitis subjects. The culture-positive patients had the highest (P < 0.05) IgG antibody levels against their autologous strains and against the reference strains of the same serotype. On the contrary, for these patients the levels of antibody against the reference strains of other serotypes were comparable to those of the nonperiodontitis subjects. The results indicated that the serum IgG antibody levels against A. actinomycetemcomitans strongly depend on the strains used as antigens in the ELISA. Elevated serum IgG levels against A. actinomycetemcomitans can be detected equally well using either the autologous strains or a variety of antigenically diverse reference strains as antigens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454165      PMCID: PMC154631          DOI: 10.1128/JCM.40.12.4640-4645.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Multiserotype enzyme-linked immunosorbent assay as a diagnostic aid for periodontitis in large-scale studies.

Authors:  P J Pussinen; T Vilkuna-Rautiainen; G Alfthan; K Mattila; S Asikainen
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Microbiological examination of root canals and periapical tissues of human teeth. Methodological studies.

Authors:  A J Möller
Journal:  Odontol Tidskr       Date:  1966-12-20

3.  Longitudinal human serum antibody responses to outer membrane antigens of Actinobacillus actinomycetemcomitans.

Authors:  J L Ebersole; M J Steffen; D Cappelli
Journal:  J Clin Periodontol       Date:  1999-11       Impact factor: 8.728

4.  Evidence for absence in northern Europe of especially virulent clonal types of Actinobacillus actinomycetemcomitans.

Authors:  D Haubek; K Poulsen; S Asikainen; M Kilian
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

5.  Titer and subclass distribution of serum IgG antibody reactive with Actinobacillus actinomycetemcomitans in localized juvenile periodontitis.

Authors:  T Y Ling; T J Sims; H A Chen; C W Whitney; B J Moncla; L D Engel; R C Page
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

6.  An ELISA for measuring serum antibodies to Actinobacillus actinomycetemcomitans.

Authors:  J L Ebersole; D E Frey; M A Taubman; D J Smith
Journal:  J Periodontal Res       Date:  1980-11       Impact factor: 4.419

7.  Structural and genetic analyses of O polysaccharide from Actinobacillus actinomycetemcomitans serotype f.

Authors:  J B Kaplan; M B Perry; L L MacLean; D Furgang; M E Wilson; D H Fine
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

8.  Rapid quantitative microenzyme-linked immunosorbent assay for tetanus antibodies.

Authors:  A K Sedgwick; M Ballow; K Sparks; R C Tilton
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

9.  Subgingival distribution of A. actinomycetemcomitans in periodontitis.

Authors:  J L Ebersole; D Cappelli; M N Sandoval
Journal:  J Clin Periodontol       Date:  1994-02       Impact factor: 8.728

10.  Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease.

Authors:  J J Zambon; J Slots; R J Genco
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

View more
  6 in total

1.  Immune response to cytolethal distending toxin of Aggregatibacter actinomycetemcomitans in periodontitis patients.

Authors:  E S Ando; L A De-Gennaro; M Faveri; M Feres; J M DiRienzo; M P A Mayer
Journal:  J Periodontal Res       Date:  2010-03-09       Impact factor: 4.419

2.  The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction.

Authors:  G P Garlet; C R B Cardoso; A P Campanelli; B R Ferreira; M J Avila-Campos; F Q Cunha; J S Silva
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

3.  Periodontitis is associated with a low concentration of vitamin C in plasma.

Authors:  Pirkko J Pussinen; Tiina Laatikainen; Georg Alfthan; Sirkka Asikainen; Pekka Jousilahti
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

4.  Tracking of plasma antibodies against Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis during 15 years.

Authors:  Laura Lakio; Johanna Antinheimo; Susanna Paju; Kåre Buhlin; Pirkko J Pussinen; Georg Alfthan
Journal:  J Oral Microbiol       Date:  2009-08-03       Impact factor: 5.474

5.  Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.

Authors:  Dominique S Michaud; Jacques Izard; Charlotte S Wilhelm-Benartzi; Doo-Ho You; Verena A Grote; Anne Tjønneland; Christina C Dahm; Kim Overvad; Mazda Jenab; Veronika Fedirko; Marie Christine Boutron-Ruault; Françoise Clavel-Chapelon; Antoine Racine; Rudolf Kaaks; Heiner Boeing; Jana Foerster; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Carlotta Sacerdote; Sabina Sieri; Domenico Palli; Rosario Tumino; Salvatore Panico; Peter D Siersema; Petra H M Peeters; Eiliv Lund; Aurelio Barricarte; José-María Huerta; Esther Molina-Montes; Miren Dorronsoro; J Ramón Quirós; Eric J Duell; Weimin Ye; Malin Sund; Björn Lindkvist; Dorthe Johansen; Kay-Tee Khaw; Nick Wareham; Ruth C Travis; Paolo Vineis; H Bas Bueno-de-Mesquita; Elio Riboli
Journal:  Gut       Date:  2012-09-18       Impact factor: 23.059

6.  Proinflammatory effect in whole blood by free soluble bacterial components released from planktonic and biofilm cells.

Authors:  Jan Oscarsson; Maribasappa Karched; Bernard Thay; Casey Chen; Sirkka Asikainen
Journal:  BMC Microbiol       Date:  2008-11-27       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.